Andrea Doria Division of Rheumatology University of Padova Via
Transcript
Andrea Doria Division of Rheumatology University of Padova Via
CURRICULUM VITAE PERSONAL INFORMATION Name Address Telephone Fax E-mail Nationality Date of birth Andrea Doria Division of Rheumatology University of Padova Via Giustiniani, 2 35128 – Padova – Italy 049/8212202 049/8212191 [email protected] Italy 29/04/1955 EXPERTISE • Principal areas of expertise He has a long-standing experience in clinical management of connective tissue disease patients. The Unit in which he works is a 3rd referral rheumatological Centre, of prominence within Italy, for the diagnosis and management of patients affected with systemic connective diseases and other rare rheumatic conditions. In addition, he has expertise in the management and follow-up of pregnant patients with systemic rheumatic diseases. Prof. Doria over 200 ISI publications are highly acknowledged. They include clinical studies describing new manifestations or subgroup of autoimmune disorders, prognostic risk factors, diagnostic tests and therapeutic interventions as well as immunochemical studies which evaluate autoantibodies, epitopes and complementary epitopes of autoantigens. (Impact Factor ISI 2010: 1033) In addition he has authored or co-authored 3 books, over 90 book chapters or Conference Proceedings and over 200 abstracts to national and International Conferences. WORK EXPERIENCE • Dates (from – to) • Name and address of employer • Type of business or sector • Occupation or position held • Main activities and responsibilities • Dates (from – to) • Name and address of employer • Type of business or sector • Occupation or position held Page 1 - Curriculum vitae of LAST_NAME, FIRST_NAME From 1988 to 1990 Hospital of Belluno, Adria e Rovigo Outpatient clinic of Rheumatology Consultant Taking care of outpatients affected with Rheumatic diseases FROM 1990 TO 2006 University-Hospital of Padova Rheumatology Assistant Professor of Rheumatology, Padova University School of Medicine Doria, Andtrea • Main activities and responsibilities • Dates (from – to) • Name and address of employer • Type of business or sector • Occupation or position held • Main activities and responsibilities Taking care of inpatients and outpatients affected with rheumatic disease; Lecturer at the Postgraduate School of Rheumatology From 2006 up to now University-Hospital of Padova Rheumatology Associate Professor of Rheumatology, Padova University School of Medicine Head of the Unit of Connective Tissue Disease and rare Rheumatic Diseases, He trained and is training many students in Medicine and in Rheumatology EDUCATION AND TRAINING • Dates (from – to) • Name and type of organization providing education and training • Principal subjects/occupational skills covered • Title of qualification awarded From 1976 to 1982 Padova University School of Medicine Medical training Medical degree • Level in national classification (if appropriate) • Dates (from – to) • Name and type of organization providing education and training • Principal subjects/occupational skills covered • Title of qualification awarded From 1982 to 1986 University of Padova, Postgraduate School of Rheumatology Residency in Reumatology Training in Rheumatology Specialist in Rheumatology • Level in national classification (if appropriate) LANGUAGES MOTHER TONGUE Italian OTHER LANGUAGES • Reading skills • Writing skills • Verbal skills ADDITIONAL INFORMATION Page 2 - Curriculum vitae of LAST_NAME, FIRST_NAME English Excellent Good Good He participates on the editorial boards of several Rheumatology and Immunology journals: Lupus, Autoimmunity, Clinical and Experimental Rheumatology, Autoimmunity Reviews, Journal of Autoimmunity, Experimental Biology and Medicine, Rheumatology Reports, Journal Autoimmunity Highlights, Reumatismo (Official Journal of Italian Society of Rheumatology), Progressi in Reumatologia (Offical Journal of Italian College of Hospital Rheumatology), Artrite e Reumatismi. Doria, Andtrea ANNEXES PUBLICATIONS ISI Pubblications of Prof. Andrea Doria 1. Gatto M, Zen M, Ghirardello A, Bettio S, Iaccarino L, Punzi L, Doria A. Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev. 2012 Sep 18. pii: S15689972(12)00213-3. doi: 10.1016/j.autrev.2012.09.003. [Epubahead of print] PubMed PMID: 23000207. 2. Tarricone E, Ghirardello A, Rampudda M, Bassi N, Punzi L, Doria A. Anti-SAE antibodies in autoimmune myositis: Identification by unlabelled protein immunoprecipitation in an Italian patient cohort. J Immunol Methods. 2012 Aug 2. [Epub ahead of print] PubMed PMID: 22884621. 3. Maestroni S, Di Corato PR, Cumetti D, Chiara DB, Ghidoni S, Prisacaru L, Cantarini L, Imazio M, Penco S, Pedrotti P, Caforio AL, Doria A, Brucato A. Recurrent pericarditis: Autoimmune or autoinflammatory? Autoimmun Rev. 2012 Aug 2. [Epub ahead of print] PubMed PMID: 22884556. 4. Doria A, Dayer JM, Punzi L. Autoinflammatory diseases: How to put the fire inside the body out? Autoimmun Rev. 2012 Aug 2. [Epub ahead of print] PubMed PMID: 22884550. 5. Doria A, Zen M, Bettio S, Gatto M, Bassi N, Nalotto L, Ghirardello A, Iaccarino L, Punzi L. Autoinflammation and autoimmunity: Bridging the divide. Autoimmun Rev. 2012 Aug 2. [Epub ahead of print] PubMed PMID: 22878274. 6. Cozzi F, Marson P, Cardarelli S, Favaro M, Tison T, Tonello M, Pigatto E, De Silvestro G, Punzi L, Doria A. Prognosis of scleroderma renal crisis: a long-term observational study. Nephrol Dial Transplant. 2012 Aug 1. [Epub ahead of print] PubMed PMID: 22859795. 7. Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis J, Cervera R, Dörner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JP, Isenberg DA, Kallenberg CG, Lightstone L, Marks SD, Martini A, Moroni G, Neumann I, Praga M, Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven RF, Zakharova H, Haubitz M, Gordon C, Jayne D, Boumpas DT. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012 Jul 31. [Epub ahead of print] PubMed PMID: 22851469. 8. Visentin M, Salmaso R, Modesti V, Ometto F, Ruffatti A, Punzi L, Doria A. Parotid, breast, and fascial involvement in a patient who fulfilled the ACR criteria for ChurgStrauss syndrome. Scand J Rheumatol. 2012;41(4):319-21. PubMed PMID: 22804574. 9. Vidalino L, Doria A, Quarta SM, Crescenzi M, Ruvoletto M, Frezzato F, Trentin L, Turato C, Parolin MC, Ghirardello A, Iaccarino L, Cavalletto L, Chemello L, Gatta A, Pontisso P. SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection. Exp Biol Med (Maywood). 2012 Jul 1;237(7):793802. Epub 2012 Jul 24. PubMed PMID: 22829702. 10. Zen M, Bassi N, Nalotto L, Canova M, Bettio S, Gatto M, Ghirardello A, Iaccarino L, Punzi L, Doria A. Disease activity patterns in a monocentric color of SLE patients: a seven-year follow-up study. Clin Exp Rheumatol. 2012 Jul 5. [Epub ahead of print] PubMed PMID: 22765883. Page 3 - Curriculum vitae of LAST_NAME, FIRST_NAME Doria, Andtrea 11. Iaccarino L, Gatto M, Bettio S, Caso F, Rampudda M, Zen M, Ghirardello A, Punzi L, Doria A. Overlap connective tissue disease syndromes. Autoimmun Rev. 2012 Jun 26. [Epub ahead of print] PubMed PMID: 22743033. 12. Manzi S, Sánchez-Guerrero J, Merrill JT, Furie R, Gladman D, Navarra SV, Ginzler EM, D'Cruz DP, Doria A, Cooper S, Zhong ZJ, Hough D, Freimuth W, Petri MA; on behalf of the BLISS-52 and BLISS-76 Study Groups. Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials. Ann Rheum Dis. 2012 May 11. [Epub ahead of print] PubMed PMID: 22550315. 13. Doria A, Cutolo M, Ghirardello A, Zen M, Villalta D, Tincani A, Punzi L, Iaccarino L, Petri M. Effect of pregnancy on serum cytokines in SLE patients. Arthritis Res Ther 2012; 14(2):R66 14. Bartoloni E, Alunno A, Bistoni O, Bizzaro N, Migliorini P, Morozzi G, Doria A, Mathieu A, Lotzniker M, Allegri F, Riccieri V, Alpini C, Gabrielli A, Tampoia M, Gerli R; On behalf of the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) investigators. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature. Autoimmun Rev 2012 Feb 27.[Epub ahead of print] PubMed PMID: 22394488 15. Bassi N, Luisetto R, Prete DD, Ghirardello A, Ceol M, Rizzo S, Iaccarino L, Gatto M, Valente M, Punzi L, Doria A. Induction of the 'ASIA' syndrome in NZB/NZWF1 mice after injection of complete Freund's adjuvant (CFA). Lupus 2012; 21: 203-9. 16. Taraborelli M, Ramoni V, Brucato A, Airò P, Bajocchi G, Bellisai F, Biasi D, Blagojevic J, Canti V, Caporali R, Caramaschi P, Chiarolanza I, Codullo V, Cozzi F, Cuomo G, Cutolo M, De Santis M, De Vita S, Di Poi E, Doria A, Faggioli P, Favaro M, Ferraccioli G, Ferri C, Foti R, Gerosa A, Gerosa M, Giacuzzo S, Giani L, Giuggioli D, Imazio M, Iudici M, Iuliano A, Leonardi R, Limonta M, Lojacono A, Lubatti C, Cerinic MM, Mazzone A, Meroni M, Meroni PL, Mosca M, Motta M, Muscarà M, Nava S, Padovan M, Pagani G, Paolazzi G, Peccatori S, Ravagnani V, Riccieri V,Rosato E, Rovere-Querini P, Salsano F, Santaniello A, Scorza R, Tani C, Valentini G, Valesini G, Vanoli M, Vigone B, Zeni S, Tincani A; on behalf of the IMPRESS investigators.. Successful pregnancies but a higher risk of preterm births in systemic sclerosis: An Italian multicentric study. Arthritis Rheum 2011 Dec 28. doi: 10.1002/art.34350. [Epub ahead of print] PubMed PMID: 22213060. 17. Gatto M, Iaccarino L, Canova M, Zen M, Nalotto L, Ramonda R, Punzi L, Doria A. Pregnancy and vasculitis: A systematic review of the literature. Autoimmun Rev 2011 Dec 3. [Epub ahead of print] PubMed PMID: 22155197. 18. Dooley MA, Jayne D, Ginzler EM, Isenberg D, Olsen NJ, Wofsy D, Eitner F, Appel GB, Contreras G, Lisk L, Solomons N; ALMS Group (Abud C, Adler S, Alarc G, Albuquerque E, Almeida F, Alvarellos A, Appel G, Avila H, Menchaca JI, Blume C, Boletis I, Bonnardeaux A, Braun A, Buyon J, Cervera R, Chen N, Chen S, Contreras G, Da Costa AG, Davids R, D'Cruz D, De Ramón E, Haya C, Deodhar A, Dooley MA, Doria A, Dussol B, Emery P, Fiechtner J, Floege J, Fragoso-Loyo H, Furie R, Ghazalli R, Ghossein C, Gilkeson G, Ginzler E, Grossman J, Gu J, Guillevin L, Hatron PY, Herrera G, Hiepe F, Houssiau F, Hübscher O, Hura C, Kaplan J, Kirsztajn G, Kiss E, Kutty GA, Laville M, Lazaro M, Lenz O, Li L, Lightstone L, Lim S, Malaise M, Manzi S, Marcos J, Meyer O, Bernard C, Monge P, Naicker S, Neal N, Neuwelt M, Neuwelt CM, Nicholls K, Olsen N, Ordi-Ros J, Ostrov B, Hershey MS, Pestana M, Petri M, Pokorny G, Pourrat J, Qian J, Radhakrishnan J, Rovin B, Sánchez-Guerrero J, Sanchez Roman J, Shanahan J, Shergy W, Skopouli F, Spindler A, Striebich C, Sundel R, Swanepoel C, Tan SY, Tate G, Tesaŕ V, Tikly M, Wang H, Yahya R, Yu X, Zhang F, Zoruba D, Houssay B, Carson P, Snaith M, Page 4 - Curriculum vitae of LAST_NAME, FIRST_NAME Doria, Andtrea Cattran D). Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med 2011; 365(20):1886-95. 19. Govoni M, Bombardieri S, Bortoluzzi A, Caniatti L, Casu C, Conti F, De Vita S, Doria A, Farina I, Ferraccioli G, Gremese E, Mansutti E, Mosca M, Padovan M, Piga M, Tincani A, Tola MR, Tomietto P, Taglietti M, Trotta F, Valesini G, Zen M, Mathieu A; Italian Society of Rheumatology. Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. Rheumatology (Oxford) 2012; 51(1):157-68. 20. Doria A, Putterman C, Sarzi-Puttini P, Szekanecz Z, Shoenfeld Y. Controversies in rheumatism and autoimmunity. Autoimmun Rev 2011 Oct 25. [Epub ahead of print] PubMed PMID: 22056979. 21. Costenbader KH, Gay S, Riquelme ME, Iaccarino L, Doria A. Genes, epigenetic regulation and environmental factors: Which is the most relevant in developing autoimmune diseases? Autoimmun Rev 2011 Oct 25. [Epub ahead of print] PubMed PMID: 22041580. 22. Rekvig OP, Putterman C, Casu C, Gao HX, Ghirardello A, Mortensen ES, Tincani A, Doria A. Autoantibodies in lupus: Culprits or passive bystanders? Autoimmun Rev 2011 Oct 25. [Epub ahead of print] PubMed PMID: 22041579. 23. Cervera R, Conti F, Doria A, Iaccarino L, Valesini G. Does sieronegative antiphospholipid syndrome really exist? Autoimmun Rev 2011 Oct 22. [Epub ahead of print] PubMed PMID: 22036830. 24. Zeher M, Doria A, Lan J, Aroca G, Jayne D, Boletis I, Hiepe F, Prestele H, Bernhardt P, Amoura Z. Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis. Lupus 2011; 20:1484-93. Epub 2011 Oct 5. PubMed PMID: 21976398. 25. Bizzaro N, Allegri F, Alpini C, Doria A, Gerli R, Lotzniker M, Mathieu A, Morozzi G, Bellisai F, Riccieri V, Tampoia M, Migliorini P. Multicentric evaluation of a second generation assay to detect antiviral citrullinated peptide antibodies: a collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni. J Clin Pathol 2011; 64(12):1139-41. 26. Illei GG, Cervera R, Burt RK, Doria A, Hiepe F, Jayne D, Pavletic S, Martin T, Marmont A, Saccardi R, Voskuyl AE, Farge D. Current state and future directions of autologous hematopoietic stem cell transplantation in sistemi lupus erythematosus. Ann Rheum Dis 2011; 70: 2071-4. 27. Musacchio E, Ramonda R, Perissinotto E, Sartori L, Hirsch R, Punzi L, Zambon S, Corti MC, Baggio G, Manzato E, Doria A, Crepaldi G. The impact of knee and hip chondrocalcinosis on disability in older people: the ProVA Study from northeastern Italy. Ann Rheum Dis 2011; 70: 1937-43. 28. Ramonda R, Lo Nigro A, Modesti V, Nalotto L, Musacchio E, Iaccarino L, Punzi L, Doria A. Atherosclerosis in psoriatic arthritis. Autoimmun Rev 2011; 10: 773-8. 29. Iaccarino L, Ghirardello A, Canova M, Zen M, Bettio S, Nalotto L, Punzi L, Doria A. Anti-annexins autoantibodies: Their role as biomarkers of autoimmune diseases. Autoimmun Rev 2011; 10(9): 553-8. 30. Orbach H, Zandman-Goddard G, Boaz M, Agmon-Levin N, Amital H, Szekanecz Z, Szucs G, Rovensky J, Kiss E, Doria A, Ghirardello A, Gomez-Arbesu J, Stojanovich L, Ingegnoli F, Meroni PL, Rozman B, Blank M, Shoenfeld Y. Prolactin and Autoimmunity : Hyperprolactinemia Correlates with Serositis and Anemia in SLE Patients. Clin Rev Allergy Immunol 2011 Feb 3. [Epub ahead of print] PubMed PMID: 21287295. 31. Ruffatti A, Ross TD, Ciprian M, Bertero MT, Salvatore S, Scarpato S, Montecucco C, Rossi S, Caramaschi P, Biasi D, Doria A, Rampudda M, Monica N, Fischetti F, Picillo U, Brucato A, Salvan E, Vittorio P, Meroni P, Tincani A.Antiphospholipid Syndrome Study Group of the Italian Society of Page 5 - Curriculum vitae of LAST_NAME, FIRST_NAME Doria, Andtrea 32. 33. 34. 35. 36. 37. 38. 39. 40. 41. 42. 43. 44. 45. Rheumatology. Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. Ann Rheum Dis 2011 Feb 1. [Epub ahead of print] PubMed PMID: 21285115. Zen M, Canova M, Campana C, Bettio S, Nalotto L, Rampudda M, Ramonda R, Iaccarino L, Doria A. The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev 2011 Jan 8. [Epub ahead of print] PubMed PMID: 21224015. Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Cervera R, Doria A, Jayne D, Khamashta MA, Kuhn A, Gordon C, Petri M, Schneider M, Shoenfeld Y, Smolen JS, Talarico R, Tincani A, Ward MM, Werth VP, Carmona L. Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice. Autoimmun Rev 2011 Jan 8. [Epub ahead of print] PubMed PMID: 21224016. Agmon-Levin N, Blank M, Zandman-Goddard G, Orbach H, Meroni PL, Tincani A, Doria A, Cervera R, Miesbach W, Stojanovich L, Barak V, Porat-Katz BS, Amital H, Shoenfeld Y. Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann Rheum Dis 2011; 70: 145-50. Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Gorza L, Doria A. Cutting Edge Issues in Polymyositis. Clin Rev Allergy Immunol 2010 Dec 30. [Epub ahead of print] PubMe Ostensen M, Brucato A, Carp H, Chambers C, Dolhain RJ, Doria A, Förger F, Gordon C, Hahn S, Khamashta M, Lockshin MD, Matucci-Cerinic M, Meroni P, Nelson JL, Parke A, Petri M, Raio L, Ruiz-Irastorza G, Silva CA, Tincani A, Villiger PM, Wunder D, Cutolo M. Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology (Oxford) 2010 Nov 18. [Epub ahead of print] PubMed PMID: 21097449. Doria A, Zen M, Canova M, Bettio S, Bassi N, Nalotto L, Rampudda M, Ghirardello A, Iaccarino L. SLE diagnosis and treatment: When early is early. Autoimmun Rev 2010; 10: 55-60. Ghirardello A, Rampudda M, Ekholm L, Bassi N, Tarricone E, Zampieri S, Zen M, Vattemi GA, Lundberg IE, Doria A. Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford) 2010; 49: 2370-4. Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN, Cervera R, Dalakas M, Doria A, Hanly JG, Huizinga TW, Isenberg D, Kallenberg C, Piette JC, Schneider M, Scolding N, Smolen J, Stara A, Tassiulas I, Tektonidou M, Tincani A, van Buchem MA, van Vollenhoven R, Ward M, Gordon C, Boumpas DT. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010; 69: 2074-82. Sarzi-Puttini P, Atzeni F, Gerli R, Bartoloni E, Doria A, Barskova T, Matucci-Cerinic M, Sitia S, Tomasoni L, Turiel M. Cardiac involvement in systemic rheumatic diseases: An update. Autoimmun Rev 2010; 9: 849-52. Caforio AL, Brucato A, Doria A, Brambilla G, Angelini A, Ghirardello A, Bottaro S, Tona F, Betterle C, Daliento L, Thiene G, Iliceto S. Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart 2010; 96: 779-84. Bassi N, Ghirardello A, Blank M, Zampieri S, Sarzi-Puttini P, Mantovani A, Shoenfeld Y, Doria A. IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus. Ann Rheum Dis 2010; 69: 170410. Amital H, Szekanecz Z, Szücs G, Dankó K, Nagy E, Csépány T, Kiss E, Doria A, Corocher N, Agmon-Levin N, Orbach H, Zandman-Goddard G, Shoenfeld Y. Serum concentrations of 25-OH Vitamin D in SLE patients are inversely related to disease activity- is it time to routinely supplement SLE patients with vitamin D? Ann Rheum Dis 2010; 69: 1155-7. Vitadello M, Doria A, Tarricone E, Ghirardello A, Gorza L. Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation. Arthritis Res Ther 2010 Mar 24; 12: R52. Losada I, Sartori L, Di Gianantonio E, Zen M, Clementi M, Doria A. Bisphosphonates in patients with autoimmune rheumatic diseases: Can they be used in women of childbearing age? Autoimmun Rev 2010; 9: 547-52. Page 6 - Curriculum vitae of LAST_NAME, FIRST_NAME Doria, Andtrea 46. 47. 48. 49. 50. 51. 52. 53. 54. 55. 56. 57. 58. Zen M, Ghirardello A, Iaccarino L, Tonon M, Campana C, Arienti S, Rampudda M, Canova M, Doria A. Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly 2010; 140(13-14): 187-201. Pisoni CN, Brucato A, Ruffatti A, Espinosa G, Cervera R, Belmonte M, Sánchez Román J, Montero Banvidez P, Tincani A, Bertero MT, Doria A, Hughes GRV, Khamashta MA. Failure of Intravenous Immunoglobulin to prevent Congenital Heart Block. Arthritis Rheum 2010; 62: 1147-52. Ginzler EM, Wofsy D, Isenberg D, Gordon C, Lisk L, Dooley MA; ALMS Group: Abud C, Adler S, Alarcón G, Albuquerque E, Almeida F, Alvarellos A, Appel G, Avila H, Blume C, Boletis I, Bonnardeaux A, Braun A, Buyon J, Cervera R, Chen N, Chen S, Contreras G, Da Costa AG, Davids R, D'Cruz D, De Ramón E, Deodhar A, Dooley MA, Doria A, Dussol B, Emery P, Fiechtner J, Floege J, Fragoso-Loyo H, Furie R, Ghazalli R, Ghossein C, Gilkeson G, Ginzler E, Gordon C, Grossman J, Gu J, Guillevin L, Hatron PY, Herrera G, Hiepe F, Houssiau F, Hübscher O, Hura C, Kaplan J, Kirsztajn G, Kiss E, Kutty GA, Laville M, Lazaro M, Lenz O, Li L, Lightstone L, Lim S, Malaise M, Manzi S, Marcos J, Meyer O, Monge P, Naicker S, Neal N, Neuwelt M, Nicholls K, Olsen N, Ordi-Ros J, Ostrov B, Pestana M, Petri M, Pokorny G, Pourrat J, Qian J, Radhakrishnan J, Rovin B, Sanchez-Guerrero J, Roman JS, Shanahan J, Shergy W, Skopouli F, Spindler A, Striebich C, Sundel R, Swanepoel C, Tan SY, Tate G, Tesar V, Tikly M, Wang H, Yahya R, Yu X, Zhang F, Zoruba D. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial. Arthritis Rheum 2010; 62: 211-21. Ometto F, Botsios C, Raffeiner B, Sfriso P, Bernardi L, Todesco S, Doria A, Punzi L. Methods used to assess remission and low disease activity in rheumatoid arthritis. Autoimmun Rev 2010; 9:1614. Zampieri S, Adami N, Biral D, Ghirardello A, Rampudda ME, Vecchiato M, Savastano S, Corbianco S, Kern H, Carraro U, Bassetto F, Merigliano S, Doria A. Polymyositis, dermatomyositis and malignancy: A further intriguing link. Autoimmun Rev 2010; 9: 449-53. Sfriso P, Ghirardello A, Botsios C, Tonon M, Zen M, Bassi N, Bassetto F, Doria A. Infections and autoimmunity: the multifaceted relationship. J Leukoc Biol 2010; 87(3): 385-95. Zampieri S, Doria A, Adami N, Biral D, Vecchiato M, Savastano S, Corbianco S, Carraro U, Merigliano S. Subclinical myopathy in patients affected with newly diagnosed colorectal cancer at clinical onset of disease: evidence from skeletal muscle biopsies. Neurol Res. 2010; 32(1): 20-5. Ghirardello A, Briani C, Lucchetta M, Doria A. Anti-ribosomal P protein antibodies and neuropsychiatric systemic lupus erythematosus: cross-sectional vs. prospective studies. Lupus 2010; 19: 771-3. Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, Cervera R, Doria A, Jayne D, Khamashta MA, Kuhn A, Gordon C, Petri M, Rekvig OP, Schneider M, Sherer Y, Shoenfeld Y, Smolen JS, Talarico R, Tincani A, van Vollenhoven RF, Ward MM, Werth VP, Carmona L. EULAR Recommendations for monitoring systemic lupus erythematosus patients in clinical practice and in observational studies. Ann Rheum Dis 2010; 69: 1269-74. Bassetto F, Vindigni V, Scarpa C, Doria A. Breast Prostheses and Connective Tissue Disease (CTD): Myth or Reality? Anesthetic Plast Surg 2010; 34: 257-63. Doria A. Atherosclerosis and lupus: what we know and what we should know. J Rheumatol 2009; 36: 2380-2. Bassi N, Zampieri S, Ghirardello A, Tonon M, Zen M, Beggio S, Matsuura E, Doria A. oxLDL/beta2GPI complex and anti-oxLDL/beta2GPI in SLE: prevalence and correlates. Autoimmunity 2009; 42: 289-91. Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, Li LS, Mysler E, SánchezGuerrero J, Solomons N, Wofsy D; Aspreva Lupus Management Study Group (Abud C, Adler S, Alarcón G, Albuquerque E, Almeida F, AlvarellosA, Appel G, Avila H, Blume C, Boletis I, Bonnardeaux A, Braun A, Buyon J, Cervera R, Chen N, Chen S, Contreras G, Da Costa AG, Davids R, D'Cruz D, De Ramón E, Deodhar A, Dooley MA, Doria A, Dussol B, Emery P, Fiechtner J, Floege J, Fragoso-Loyo H, Furie R, Ghazalli R, Ghossein C, Gilkeson G, Ginzler E, Gordon C, Page 7 - Curriculum vitae of LAST_NAME, FIRST_NAME Doria, Andtrea 59. 60. 61. 62. 63. 64. 65. 66. 67. 68. 69. 70. 71. 72. 73. 74. Grossman J, Gu J, Guillevin L, Hatron PY, Herrera G, Hiepe F, Houssiau F, Hübscher O, Hura C, Kaplan J, Kirsztajn G, Kiss E, Kutty GA, Laville M, Lazaro M, Lenz O, Li L, Lightstone L, Lim S, Malaise M, Manzi S, Marcos J, Meyer O, Monge P, Naicker S, Neal N, Neuwelt M, Nicholls K, Olsen N, Ordi-Ros J, Ostrov B, Pestana M, Petri M, Pokorny G, Pourrat J, Qian J, Radhakrishnan J, Rovin B, Sánchez-Guerrero J, Sanchez Roman J, Shanahan J, Shergy W, Skopouli F, Spindler A, Striebich C, Sundel R, Swanepoel C, Tan SY, Tate G, Tesaŕ V, Tikly M, Wang H, Yahya R, Yu X, Zhang F, Zoruba D. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol. 2009; 20: 1103-12. Turiel M, Atzeni F, Tomasoni L, de Portu S, Delfino L, Bodini BD, Longhi M, Sitia S, Bianchi M, Ferrario P, Doria A, Colonna VD, Sarzi-Puttini P. Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients. Rheumatology (Oxford) 2009; 48: 834-9. Ghirardello A, Bendo R, Rampudda ME, Bassi N, Zampieri S, Doria A. Commercial blot assays in the diagnosis of systemic rheumatic diseases. Autoimmun Rev 2009; 8: 645-9. Vidalino L, Doria A, Quarta S, Zen M, Gatta A, Pontisso P. SERPINB3, apoptosis and autoimmunity. Autoimmun Rev 2009; 9: 108-12. Gordon C, Jayne D, Pusey C, Adu D, Amoura Z, Aringer M, Ballerin J, Cervera R, Calvo-Alén J, Chizzolini C, Dayer J, Doria A, Ferrario F, Floege J, Guillevin L, Haubitz M, Hiepe F, Houssiau F, Lesavre P, Lightstone L, Meroni P, Meyer O, Moulin B, O'Reilly K, Praga M, Schulze-Koops H, Sinico R, Smith K, Tincani A, Vasconcelos C, Hughes G. European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus. 2009;18(3):257-263. Briani C, Lucchetta M, Ghirardello A, Toffanin E, Zampieri S, Ruggero S, Scarlato M, Quattrini A, Bassi N, Ermani M, Battistin L, Doria A. Neurolupus is associated with anti-ribosomal P protein antibodies: An inception cohort study. J Autoimmun 2009; 32: 79-84. Moroni G, Doria A, Ponticelli C. Cyclosporine (CsA) in lupus nephritis: assessing the evidence. Nephrol Dial Transplant. 2009; 24(1): 15-20. Bassi N, Zampieri S, Ghirardello A, Tonon M, Zen M, Cozzi F, Doria A. Pentraxins, Anti-pentraxin Antibodies, and Atherosclerosis. Clin Rev Allergy Immunol 2009; 37: 36-43. Ruffatti A, Del Ross T, Ciprian M, Nuzzo M, Rampudda M, Bertero MT, Bergia R, Caramaschi P, Biasi D, Capsoni F, Montaguti L, Ruffini R, Brucato A, Picillo U, Fanelli V, Riccieri V, Piccoli A, Valesini G, Doria A, Meroni PL, and Tincani A. Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicenter retrospective follow-up study. Ann Rheum Dis 2009; 68: 397-9. Imbasciati E, Tincani A, Gregorini G, Doria A, Moroni G, Cabiddu G, Marcelli D. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant 2009; 24(2): 519-25. Imazio M, Brucato A, Doria A, Brambilla G, Ghirardello A, Romito A, Natale G, Palmieri G, Trinchero R, Adler Y. Antinuclear antibodies in recurrent idiopathic pericarditis: Prevalence and clinical significance. Int J Cardiol 2009; 136: 289-93. Doria A, Briani C. Primary prevention of systemic lupus erythematosus. Nat Clin Pract Rheumatol 2008; 4(11): 576-7. Doria A, Sarzi-Puttini P, Shoenfeld Y. Infections, rheumatism and autoimmunity: the conflicting relationship between humans and their environment. Autoimmun Rev 2008; 8(1):1-4. Doria A, Canova M, Tonon M, Zen M, Rampudda E, Bassi N, Atzeni F, Zampieri S, Ghirardello A. Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev 2008; 8(1):24-8. Doria A, Zampieri S, Sarzi-Puttini P. Exploring the complex relationships between infections and autoimmunity. Autoimmun Rev 2008; 8(2): 89-91. Brucato A, Maestroni S, Cumetti D, Thiella G, Alari G, Brambilla G, Imazi M, Doria A, Palmieri G, Adler Y. Recurrent pericarditis: infectious or autoimmune? Autoimmun Rev 2008; 8: 44-7. Doria A, Tincani A, Lockshin M. Challenges of lupus pregnancies. Rheumatology (Oxford) 2008; 47: iii9-iii12. Page 8 - Curriculum vitae of LAST_NAME, FIRST_NAME Doria, Andtrea 75. 76. 77. 78. 79. 80. 81. 82. 83. 84. 85. 86. 87. 88. 89. 90. 91. 92. 93. Doria A, Bajocchi G, Tonon M, Salvarani C. Pre-pregnancy counselling of patients with vasculitis. Rheumatology (Oxford) 2008; 47: iii13-iii15. ∅stensen M, Lockshin M, Doria A, Valesini G, Meroni P, Gordon C, Brucato A, Tincani A.Update on safety during pregnancy of biological agents and some immunosuppressive antirheumatic drugs. Rheumatology (Oxford) 2008; 47: iii28-iii31. Cooke A, Ferraccioli G, Herrmann M, Romani L, Schulze C, Zampieri S, Doria A. Induction and protection of autoimmune rheumatic diseases. the role of infections. Clin Exp Rheumatol 2008; 26 (Suppl. 48): S1-S7. Claesson MH, Nicoletti F, Stosic-Grujicic S, Doria A, Zampieri S. Interactions between infections and immune-inflammatory cells in type i diabetes mellitus and inflammatory bowel diseases: evidences from animal models. Clin Exp Rheumatol 2008; 26 (Suppl. 48): S8-S11. Girschick HJ, Guilherme L, Inman RD, Latsch K, Rihl M, Sherer Y, Shoenfeld Y, Zeidler H, Arienti S, Doria A. Bacterial triggers and rheumatic diseases. Clin Exp Rheumatol 2008; 26 (Suppl. 48): S12-S17. Avcin T, Canova M, Guilpain P, Guillevin L, Kallenberg CGM, Tincani A, Tonon M, Zampieri S, Doria A. Infections, connective tissue diseases and vasculitis. Clin Exp Rheumatol 2008; 26 (Suppl. 48): S18-S26. Efthimiou P, Flavell RA, Furlan A, Gasbarrini G, Gava A, Koné-Paut I, Manna R, Punzi L, Sutterwala FS, Touitou I, Doria A. Autoinflammatory syndromes and infections: pathogenetic and clinical implications. Clin Exp Rheumatol 2008; 26 (Suppl. 48): S53-S61. Lalvani A, Meroni PL, Millington KA, Modolo ML, Plebani M, Tincani A, Villalta D, Doria A, Ghirardello A. Recent advances in diagnostic technology: applications in autoimmune and infectious diseases. Clin Exp Rheumatol 2008; 26 (Suppl. 48): S62-S66. Zara G, Ermani M, Rondinone R, Arienti S, Doria A. Thalidomide and sensory neurotoxicity: A neurophysiological study. J Neurol Neurosur Ps 2008; 79(11): 1258-61. Epub 2008 May 1. Zampieri S, Biral D, Adami N, Ghirardello A, Rampudda ME, Tonello M, Doria A. Expression of myositis specific autoantigens during post-natal myogenesis. Neurol Res 2008; 30: 145-8. Doria A, Briani C. Lupus: improving long-term prognosis. Lupus 2008; 17: 166-70. Bassi N, Amital D, Amital H, Doria A, Shoenfeld Y. Chronic fatigue syndrome: characteristics and possible causes for its pathogenesis. Isr Med Assoc J 2008; 10: 79-82. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y, Abu-Shakra M, Barzilai O, Berkun Y, Blank M, de Carvalho JF, Doria A, Gilburd B, Katz U, Krause I, Langevitz P, Orbach H, Pordeus V, Ram M, Toubi E, Sherer Y. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases--2008. Isr Med Assoc J 2008; 10: 8-12. Foti R, Leonardi R, Rondinone R, Di Gangi M, Leonetti C, Canova M, Doria A. Scleroderma-like disorders. Autoimmun Rev 2008; 7: 331-9. Doria A, Arienti S, Rampudda M, Canova M, Tonon M, Sarzi-Puttini P. Preventive strategies in systemic lupus erythematosus. Autoimmun Rev 2008; 7: 192-7. Atzeni F, Doria A, Ghirardello A, Turiel M, Batticciotto A, Carrabba M, Sarzi-Puttini P. Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical value. Autoimmunity 2008; 41: 111-5. Briani C, Doria A, Ruggero S, Toffanin E, Luca M, Albergoni MP, D'Odorico A, Grassivaro F, Lucchetta M, De Lazzari F, Balzani I, Battistin L, Vernino S. Antibodies to muscle and ganglionic acetylcholine receptors (AchR) in celiac disease. Autoimmunity 2008; 41: 100-4. Atzeni F, Doria A, Ghirardello A, Villalta D, Zampieri S, Carrabba M, Sarzi-Puttini P. Organ-specific autoantibodies in patients with rheumatoid arthritis treated with adalimumab: a prospective longterm follow-up. Autoimmunity 2008; 41: 87-91. Sarzi-Puttini P, Atzeni F, Di Franco M, Lama N, Batticciotto A, Iannuccelli C, Dell'Acqua D, de Portu S, Riccieri V, Carrabba M, Buskila D, Doria A, Valesini G. Anti-polymer antibodies are correlated with pain and fatigue severity in patients with fibromyalgia syndrome. Autoimmunity 2008; 41: 749. Page 9 - Curriculum vitae of LAST_NAME, FIRST_NAME Doria, Andtrea 94. 95. 96. 97. 98. 99. 100. 101. 102. 103. 104. 105. 106. 107. 108. 109. Sarzi-Puttini P, Doria A. Organ specific-autoantibodies: their role as markers and predictors of disease. Autoimmunity 2008; 41: 1-10. Sarzi-Puttini P, Buskila D, Carabba M, Doria A, Atzeni F. Treatment strategy in Fibromyalgia syndrome: where are we now? Semin Arthritis Rheum 2008; 37(6): 353-65. Bassi N, Ghirardello A, Iaccarino L, Zampieri S, Rampudda ME, Atzeni F, Sarzi-Puttini P, Shoenfeld Y, Doria A. OxLDL/β2GPI-anti-oxLDL/β2GPI complex and atherosclerosis in SLE patients. Autoimmunity Rev 2007; 7: 52-8. Iaccarino L, Arienti S, Rampudda M, Canova M, Atzeni F, Sarzi Puttini P, Doria A. Mycophenolate mofetil in lupus glomerulonephritis: effectiveness and tolerability. Ann N Y Acad Sci 2007; 1110:516-24. Shoenfeld Y, Szyper-Kravitz M, Witte T, Doria A, Tsutsumi A, Tatsuya A, Dayer JM, Roux-Lombard P, Fontao L, Kallenberg CG, Bijl M, Matthias T, Fraser A, Zandman-Goddard G, Blank M, Gilburd B, Meroni PL. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann N Y Acad Sci 2007;1108: 227-39. Atzeni F, Doria A, Sarzi-Puttini P. What is the role of rituximab in the treatment of rheumatoid arthritis? Autoimm Rev 2007; 6(8): 553-8. Atzeni F, Doria A, Carrabba M, Turiel M, Sarzi-Puttini P. Potential terget of Infliximab in autoimmune and inflammatory diseases. Autoimm Rev 2007; 6: 529-36. Zampieri S, Ghirardello A, Rossini K, Iaccarino L, Bassi N, Atzeni F, Sarzi-Puttini P, Doria A. Antigen preparation for immunological studies in systemic autoimmune diseases. Ann N J Acad Sci 2007; 1109: 193-202. Ghirardello A, Villalta D, Morozzi G, Afeltra A, Galeazzi M, Gerli R, Mathieu A, Meroni P, Migliorini P, Radica A, Ricceri V, Ruffatti A, Sebastiani GD, Tincani A, Doria A, on Behalf of FIRMA Group. Evaluation of current methods for the m easurement of serum anti-double-stranded DNA antibodies. Ann N J Acad Sci 2007; 1109: 401-406. Ghirardello A, Bizzaro N, Zampieri S, Iaccarino L, Bassi N, Tozzoli R, Ruffatti A, Villalta D, Tonutti E, Doria A. Biological and clinical relevance of anti-prothrombin antibodies. Ann N Y Acad Sci 2007;1109:503-10. Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, Danko K, Nagy E, Csepany T, Carvalho JF, Doria A, Shoenfeld Y. Novel Biomarkers in Autoimmune Diseases: Prolactin, Ferritin, Vitamin D, and TPA Levels in Autoimmune Diseases. Ann N Y Acad Sci. 2007; 1109:385-400. Bizzarro N, Ghirardello A, Zampieri S, Iaccarino L, Tozzoli R, Ruffatti A, Villalta D, Doria A. Antiprothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study. J Thromb Haemost 2007 5: 1158-64. Mosca M, Strigini F, Doria A, Iaccarino L, Pratesi F, Tani C, Zampieri S, D Chimenti, Ghirardello A, Carmignani A, Cecchi M, Migliorini P, Bombardieri S. Anti-C1q antibodies in pregnant patients with systemic lupus erythematosus. Clin Exp Rheumatol 2007; 25: 449-52. Gerosa M, Cimaz R, Stramba-Badiale M, Goulene K, Meregalli E, Trespidi L, Acaia B, Tincani A, Danieli E, Motta M, Doria A, Zulian F, Brucato A, Riboldi P, Meroni PL. Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases: a multicenter prospective study. Rheumatology 2007; 46: 1285-9. Iaccarino L, Rampudda ME, Canova M, Della Libera S, Sarzi-Puttini P; Doria A. Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases? Autoimmunity Rev 2007; 6: 190-5. Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S, Manno C, Altieri P, Ferrara R, Greco S, Ponticelli C. A Randomized Pilot Trial Comparing Cyclosporine and Azathioprine for Maintenance Therapy in Diffuse Lupus Nephritis over Four Years. Clin J Am Soc Nephrol 2006; 1: 925-32. Page 10 - Curriculum vitae of LAST_NAME, FIRST_NAME Doria, Andtrea 110. Hengstman GJD, ter Laak HJ, Vree Egberts WTM, Lundberg IE, Moutsopoulos HM, Vencovsky J, Doria A, Mosca M, van Venrooij WJ, van Engelen BGM. Anti-SRP autoantibodies, marker of a necrotizing myopathy. Ann Rheum Dis 2006; 65: 1635-1638. 111. Doria A, Iaccarino L, Arienti S, Rampudda ME, Canova MG, Rondinone R, Todesco S. Mycophenolate mofetil and systemic lupus erythematosus. Lupus 2006; 15 Supplement: 44-54. 112. Shoenfeld Y, Howard JA. Carp HJA, Molina V, Blank M, Cervera R, Tincani A, Faden D, Lojacono A, Doria A, Konova E, Meroni PL. Autoantibodies and Prediction of Reproductive Failure. Am J Reprod Immunol 2006; 337-44. 113. Briani C, Doria A, Marcolongo R, Tognon S, Ruggero S, Toffanin E, Ermani M Ghirardello A, Zampieri S, Semenzato G. Increased titres of IgM anti-heparan sulfate antibody in Behçet’s Disease. Clin Exp Rheumatol 2006; 24(5 Suppl 42): S104-7. 114. Tincani A, Danieli E, Nuzzo M, Scarsi M, Motta M, Cimaz R, Lojacono A, Nacinovich R, Taddei F, Doria A, Brucato A, Meroni PL and for the Pregnancy Study Group of Italian Society of Rheumatology. Impact of in utero environment on the offspring of lupus patients. Lupus 2006; 15: 801-7. 115. Doria A, Sfriso P. Adalimumab in Psoriatic Arthritis. Drugs 2006; 66: 1497-99. 116. Østensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, Doria A, Rai R, Meroni PL, Cetin I, Derksen R, Branch W, Motta M, Gordon C, Ruiz-Irastorza G, Spinillo A, Friedman D, Cimaz R, Czeizel A, Piette JC, Cervera R, Levy R, Clementi M, De Carolis S, Petri M, Shoenfeld Y, Faden D, Valesini G, Tincani A. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006; 8 (3): 209. 117. Doria A, Iaccarino L, Ghirardello A, Zampieri S, Arienti S, Sarzi-Puttini P, Atzeni F, Piccoli A, Todesco S. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 2006; 119: 1497-1499. 118. Doria A, Iaccarino L, Arienti S, Ghirardello A, Zampieri S, Rampudda ME, Cutolo M, Tincani A, Todesco S. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol 2006; 22(2): 234-241 119. Sarzi-Puttini P, Atzeni F, Diana A, Doria A, Furlan R. Increased Neural Sympathetic Activation in Fibromyalgia syndrome. Ann NY Acad Sci 2006; 1069: 109-17. 120. Doria A, Iaccarino L, Sarzi-Puttini P, Ghirardello A, Zampieri S, Arienti S, Cutolo M, Todesco S. Estrogens in Pregnancy and systemic lupus erythematosus. Ann NY Acad Sci 2006; 1069: 24756. 121. Tarricone E, Ghirardello A, Zampieri S, Rampudda ME, Doria A, Gorza L. Cell stress-response in skeletal muscle myofibers. Ann NY Acad Sci 2006; 1069: 472-6. 122. Briani C, Doria A, Sarzi-Puttini P, Dalakas MC. Update on idiopathic inflammatory myopathies. Autoimmunity. 2006; 39: 161-70. 123. Zampieri S, Ghirardello A, Iaccarino L, Briani C, Sarzi-Puttini P, Atzeni F, Arienti S, Todesco S, Doria A. Polymyositis-dermatomyositis and infections. Autoimmunity 2006; 39: 191-6. 124. Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C, Rondinone R, Sarzi-Puttini P, Todesco S, Doria A. Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity 2006; 39(3): 217-21. 125. Doria A, Iaccarino L, Ghirardello A, Arienti S, Zampieri S, Rampudda ME, Tincani A, Todesco S. Seltene autoimmune rheumatische erkrankungen in der schwangerschaft: systemische sklerose, dermato-polymyositis und vaskulitiden. Z Rheumatol 2006; 65: 200-208. 126. Brucato A, Brambilla G, Moreo A, Alberti A, Munforti C, Ghirardello G, Doria A, Shinar Y, Livneh A, Adler Y, Shoenfeld Y, Palmieri G, Spodick DH. Long term outcomes in difficult to treat recurrent pericarditis. Am J Cardiol 2006; 98(2): 267-271. 127. Rinaldi S, Ghisi M, Iaccarino L, Zampieri S, Ghirardello A, Sarzi-Puttini P, Perini G, Todesco S, Sanavio E, Doria A. Influence of coping skills on health-related quality of life in SLE patients. Arthritis Rheum 2006; 55: 427-33. 128. Tincani A, Bompane D, Danieli E, Doria A. Pregnancy, lupus and antiphosphpolipid syndrome (Huges syndrome). Lupus 2006; 15: 156-60. Page 11 - Curriculum vitae of LAST_NAME, FIRST_NAME Doria, Andtrea 129. Drosera M, Facchetti F, Landolfo S, Mondini M, Nyberg F, Parodi A, Santoro A, Zampieri S, Doria A. Role of soluble and cell surface molecules in the pathogenesis of autoimmune skin disease. Clin Exp Rheumatol 2006; 24: S7-S13. 130. Bano S, Bombardieri S, Doria A, Iaccarino L, Lehmann P, Mosca M, Rondinone R, Sontheimer RD, Kuhn A. Lupus erythematosus and the skin. Clin Exp Rheumatol 2006; 24: S26-S35. 131. Asherson RA, Francès C, Iaccarino L, Khamashta MA, Malacarne F, Piette JC, Tincani A, Doria A. The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy. Clin Exp Rheumatol 2006; 24: S46-S51. 132. Griffiths CEM, Iaccarino L, Naldi L, Olivieri I, Pipitone N, Salvarani C, Doria A. Psoriasis and psoriatic arthritis: immunological aspects and therapeutic guidelines. Clin Exp Rheumatol 2006; 24: S72-S78. 133. Galeazzi M, Gasbarrini G, Ghirardello A, Grandemange S, Hoffman HM, Manna R, Podswiadek M, Punzi L, Sebastiani GD, Touitou I, Doria A. Autoinflammatory syndromes. Clin Exp Rheumatol 2006; 24: S79-S85. 134. Hengstman GJD, Vree Egberts WTM, Seelig HP, Lundberg IE, Moutsopoulos HM, Doria A, Mosca M, Vencovsky J, van Venrooij WJ, van Engelen BGM. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2β antigen. Ann Rheum Dis 2006; 65: 242-5. 135. Karassa FB., Afeltra A, Ambrozic A, Chang D-M, De Keyser F, Doria A, Galeazzi M, Hirohata S, Hoffman IEA, Inanc M, Massardo L, Mathieu A, Mok CC, Morozzi G, Sanna G, Spindler AJ, Tzioufas AG, Yoshio T, Ioannidis JPA. Accuracy of Anti-Ribosomal P Protein Antibody Testing for Diagnosis of Neuropsychiatric Systemic Lupus Erythematosus: An International Meta-Analysis. Arthritis Rheum 2006; 54: 312-24. 136. Doria A, Sarzi-Puttini P, Shoenfeld Y. 2nd Conference on Heart, Rheumatism and Autoimmunity, Pescara, Italy. May 19 – 20, 2005. Autoimmunity Rev 2006; 5(1):55-63. 137. Zampieri S, Alaibac M, Iaccarino L, Rondinone R, Ghirardello A, Sarzi-Puttini P, Peserico A, Doria A. TNF-{alpha} is expressed in refractory skin lesions from subacute cutaneous lupus erythematosus patients. Ann Rheum Dis 2006; 65(4): 545-8. 138. Shoenfeld Y, Gerli R, Doria A, Matsuura E, Matucci Cerinic M, Ronda N, Jara LJ, Abu-Shakra M, Meroni PL, Sherer Y. Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases. Circulation 2005; 112: 3337-47. 139. Sarzi-Puttini P, Atzeni F, Iaccarino L, Doria A. Environment and systemic lupus erythematosus: an overview. Autoimmunity 2005: 38: 465-72. 140. Sarzi-Puttini P, Atzeni F, Capsoni F, Lubrano E, Doria A. Drug-induced lupus erythematosus. Autoimmunity 2005: 38: 507-18. 141. Briani C, Zara G, Rondinone R, Iaccarino L, Ruggero S, Toffanin E, Ermani M, Ghirardello A, Zampieri S, Sarzi-Puttini P, Doria A. Positive and negative effects of thalidomide on refractory cutaneous lupus erythematosus. Autoimmunity 2005: 38: 549-55. 142. Tincani A, Rebaioli CB, Frassi M, Taglietti M, Gorla R, Cavazzana I, Faden D, Taddei F, Lojacono A, Motta M, Trepidi L, Meroni P, Cimaz R, Ghirardello A, Doria A, Pisoni MP, Muscara M, Brucato A; Pregnancy Study Group of Italian Society of Rheumatology. Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome. Autoimmun Rev. 2005; 4(7): 423-8. 143. Doria A, Sarzi-Puttini P. Heart, rheumatism and autoimmunity: an old intriguing link. Lupus 2005; 14 (9): 643-6. 144. Brucato A, Shinar Y, Brambilla G, Robbiolo L, Ferrioli G, Patrosso MC, Zanni D, Penco S, Boiani E, Ghirardello A, Caforio ALP, Bergantin A, Tombini V, Moreo A, Ashtamkar L, Doria A, Shoenfeld Y, Livneh A. Idiopathic recurrent acute pericarditis: Familial Mediterranean Fever mutations and disease evolution in a large cohort of Caucasian patients. Lupus 2005; 14 (9): 670-4. 145. Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus 2005; 14 (9): 683-6. Page 12 - Curriculum vitae of LAST_NAME, FIRST_NAME Doria, Andtrea 146. Atzeni F, Sarzi-Puttini P, Doria A, Boiardi L, Pipitone N, Salvarani C. Behçet’s disease and cardiovascular involvement. Lupus 2005; 14 (9): 723-6. 147. Turiel M, Peretti R, Sarzi-Puttini P, Atzeni F, Doria A. Cardiac imaging techniques in systemic autoimmune diseases. Lupus 2005; 14 (9): 727-31. 148. Sarzi-Puttini P, Atzeni F, Turiel M, Iaccarino L, Doria A. Tumor necrosis factor-α, biological agents and cardiovascular risk. Lupus 2005; 14 (9): 780-4. 149. Zandman-Goddard G, Blank M, Langevitz P, Slutsky L, Pras M, Levy Y, Shovman O, Witte T, Doria A, Rovensky J, Shoenfeld Y. Anti-serum amyloid component P (SAP) antibodies in SLE patients correlate with disease activity. Ann Rheum Dis 2005; 64: 1698-1702. 150. Turiel M, Sarzi-Puttini P, Peretti R, Rossi E, Atzeni F, Parsons W, Doria A. Thrombotic risk factors in primary antiphospholipid syndrome: a five-year prospective study. Stroke 2005; 36(7): 1490-4. 151. Turiel M, Sarzi-Puttini P, Peretti R, Ionizzato S, Muzzupappa S, Atzeni F, Rossi E, Doria A. Fiveyear follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome. Am J Cardiol 2005; 96(4): 574-9. 152. Zampieri S, Iaccarino L, Ghirardello A, Tarricone E, Arienti S, Sarzi-Puttini Piercarlo, Gambari PF, Doria A. Systemic lupus erythematosus, atherosclerosis, and autoimmunity. Ann NY Acad Sci 2005; 1051:351-61. 153. Atzeni F, Turiel M, Capsoni F, Doria A, Meroni PL; Sarzi-Puttini P. Autoimmunity anti-TNFα agents. Ann NY Acad Sci 2005; 1051:559-69. 154. Villalta D, Tozzoli R, Bizzaro N, Tonutti E, Ghirardello A, Doria A. The relevance of autoantigen source and cutoff definition in antichromatin (nucleosome) antibody immunoassays. Ann N Y Acad Sci 2005 Jun;1050:176-84. 155. Doria A, Sherer Y, Meroni PL, Shoenfeld Y. Inflammation and accelerated atherosclerosis – Basic mechanisms. Rheum Dis Clin N Am 2005; 31: 329-54. 156. Doria A, Mosca M, Gambari PF, Bombardieri S. Defining unclassifiable connective tissue diseases: incomplete, undifferentiated or both? J Rheumatol 2005; 32: 213-5. 157. Kuhn A, Rondinone R, Doria A, Shoenfeld Y. 1st International Conference on Cutaneous Lupus Erythematosus. Düsseldorf, Germany, September 1-4, 2004. Autoimmunity Rev 2005: 4: 66-78. 158. Capsoni F, Sarzi-Puttini P, Atzeni F, Minonzio F, Bonara P, Doria A, Carrabba M. Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis. Arthritis Res Ther 2005; 7: R250-R255. 159. Zampieri S, Ghirardello A, Iaccarino L, Tarricone E, Gambari PF, Doria A. Anti-JO-1 antibodies. Autoimmunity 2005; 38: 73-78. 160. Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Gambari PF, Doria A. Anti-MI-2 antibodies. Autoimmunity 2005; 38: 79-83. 161. Atzeni F, Sarzi-Puttini P, Doria A, Iaccarino L, Capsoni F. Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review. Autoimmunity Rev 2005; 4(3):144-52. 162. Ghirardello A, Doria A, Zampieri S, Tarricone E, Tozzoli R, Villalta D, Bizzaro N, Piccoli A, Gambari PF. Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. J Autoimmunity 2004; 22: 235-40. 163. Doria A, Shoenfeld Y, Pauletto P. Premature coronary disease in systemic lupus. N Eng J Med 2004; 350(15):1571-5. 164. Marai I, Shoenfeld Y, Bizzaro N, Villalta D, Doria A, Tonutti E, Tozzoli R. IgA and IgG tissue transglutaminase antibodies in systemic lupus erythematosus. Lupus 2004; 13(4): 241-4. 165. Briani C, Zara G, Rondinone R, Della Libera S, Ermani M, Ruggero S, Ghirardello A, Zampieri S, Doria A. Thalidomide neurotoxicity: prospective study in patients with lupus erythematosus. Neurology 2004: 62: 2288-90. 166. Doria A, Sarzi Puttini PC, Shoenfeld Y. Heart Rheumatism and Autoimmunity. Milan, Italy. February 5-7, 2004. Autoimmunity Rev 2004; 3 (4): 337-354. 167. Doria A, Iaccarino L, Ghirardello A, Briani C, Zampieri S, Tarricone E, Gambari PF. Pregnancy in rare autoimmune rheumatic diseases: UCTD, MCTD, myositis, systemic vasculitis, and Beçhet disease. Lupus 2004; 13 (9): 690-5. Page 13 - Curriculum vitae of LAST_NAME, FIRST_NAME Doria, Andtrea 168. Rinaldi S, Doria A, Salaffi F, Ermani M, Iaccarino L, Ghirardello A, Zampieri S, Gambari PF, Perini G. Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age. Rheumatology 2004; 43: 1574-9. 169. Doria A, Rinaldi S, Ermani M, Salaffi F, Iaccarino L, Ghirardello A, Zampieri S, Della Libera S, Perini G, Todesco S. Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological, and psychological determinants. Rheumatology 2004; 43: 1580-6. 170. Doria A, Ghirardello A, Iaccarino L, Zampieri S, Punzi L, Tarricone E, Ruffatti A, Sulli A, Sarzi Puttini PC, Gambari PF, Cutolo M. Pregnancy, cytokines and disease activity in systemic lupus erythematosus. Arthritis Rheum 2004; 51: 989-995. 171. Villata D, Romelli PB, Savina C, Bizzarro N, Bozzoli R, Tonutti E, Ghirardello A, Doria A. AntidsDNA antibody avidità determination by simple reliable ELISA method for SLE diagnosis and monitorino. Lupus 2003; 12: 31-36. 172. Zampieri S, Mahler M, Blüthner M, Qiu Z, Malmegrim K, Ghirardello A, Doria A, van Venrooij WJ, Raats JMH. Recombinant anti-P proteins autoantibodies isolated from a human autoimmune library: reactivity, specificity and epitope recognition. Cell Mol Life Sci 2003; 60: 588-98. 173. Doria A, Shoenfeld Y, Wu R, Gambari PF, Puato M, Ghirardello A, Gilburd B, Corbanese S, Patnaik M, Zampieri S, Peter JB, Favaretto E, Iaccarino L, Sherer Y, Todesco S, Pauletto P. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with Systemic Lupus Erythematosus. Ann Rheum Dis 2003, 62: 1071-77. 174. Bizzaro N, Villalta D, Tonutti E, Doria A, Tampoia M, Bassetti D, Tozzoli R. IgA AND IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis. Digest Dis Sci 2003; 48: 2360-5. 175. Righi A, Schiavon F, Jablonska S, Doria A, Blasczyk M, Rondinone R, Todesco S. Intravenous immunoglobulins control scleromyxoedema. Ann Rheum Dis 2002; 61: 59-61. 176. Doria A, Cutolo M, Ghirardello A, Zampieri S, Vescovi F, Sulli A, Giusti M, Piccoli A, Grella P Gambari PF. Steroid hormones and disease activity during pregnancy in systemic lupus eythematosus. Arthritis Rheum 2002; 47: 202-9. 177. Casonato A, Pontara E, Doria A, Bertomoro A, Cattini MG, Gambari PF, Girolami A. Lack of multimer organization of von Willebrand factor in an acquired con Willebrand syndrome. Br J Haematol 2002; 116: 899-904. 178. Ostuni P, Botsios C, Sfriso P, Bertagnin A, Cozzi F, Doria A, Todesco S. Prevalence and clinical features of fibromyalgia in systemic lupus erythematosus, systemic sclerosis and Sjogren's syndrome. Minerva Med 2002; 93(3):203-9. 179. Franceschini F, Cavazzana I, Generali D, Quinzanini M, Ghirardello A, Doria A, Cattaneo R. Anti-Ku Antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients. J Rheumatol 2002; 29: 1393-7. 180. Ghirardello A, Caponi L, Franceschini F, Zampieri S, Gambari PF, Doria A. Diagnostic tests for antiribosomal P protein antibodies: a comparative evaluation of immunoblotting and ELISA assays. J Autoimmunity 2002; 19: 71-77. 181. Brucato A, Franceschini F, Doria A, Cimaz R, Meroni P, Tincani A, Pisoni M, Faden D, Motta M, Frassi M, Castellino G, Tombini V, Canesi B. Pathogenetic associations of maternal Anti-Ro/SSA antibodies. Lupus 2002; 11: 650-650. 182. Brucato A, Doria A, Frassi M, Castellino G, Franceschini F, Faden D, Pisoni MP, Solerte L, Muscarà M, Lojacono A, Motta M, Cavazzana I, Ghirardello A, Vescovi F, Tombini V, Cimaz R, Gambari PF, Meroni PL, Canesi B, Tincani A. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus 2002; 11: 716-721. 183. Zampieri S, Degen W, Ghirardello A, Doria A, van Venrooij WJ. Dephosphorylation of autoantigenic ribosomal P proteins during FAS-L induced apoptosis; a possible trigger for the development of the autoimmune response in SLE patients. Ann Rheum Dis 2001; 60: 72-76. 184. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden R, Pisoni MP, Muscarà M, Vignati G, Stramba-Badiale M, Catelli L, Lojacono A, Cavazzana I, Ghirardello A, Vescovi F, Gambari PF, Doria A, Meroni PL, Tincani A.. Risk of congenital complete heart block in newborns of mothers Page 14 - Curriculum vitae of LAST_NAME, FIRST_NAME Doria, Andtrea 185. 186. 187. 188. 189. 190. 191. 192. 193. 194. 195. 196. 197. 198. 199. 200. with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis:. A prospective study of 100 women. Arthritis Rheum 2001; 44: 1832-35. Ghirardello A, Doria A, Zampieri S, Gambari PF, Todesco S. Autoantibodies to ribosomal P proteins in systemic lupus erythematosus. Isr Med Assoc J 2001; 3(11): 854-7. Zampieri S, Ghirardello A, Doria A, Tonello M. Bendo R, Rossini K, Gambari PF. The use of Tween 20 in immunoblotting assays for the detection of autoantibodies in connective tissue diseases. J Immunol Methods 2000; 239: 1-11. Ghirardello A, Doria A, Zampieri S, Gerli R, Rapizzi E, Gambari PF. Anti ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with the IgG anticardiolipin antibodies. Ann Rheum Dis 2000; 59: 975-981. Anselmino M, Zaninotto G, Costantini M, Ostuni PA, Ianiello A, Boccù C, Doria A, Todesco S, Ancona E. Esophageal motor function in primary Sjögren syndrome. Correlation with dysphagia and xerostomia Dig Dis Sci 1997; 42: 113-8. George J, Gilburg B, Levy Y, Afec A, Damianovitch M, Ghirardello A, Doria A, Todesco S, Shoenfeld Y. "Autoantibody dominance" pattern following idiotypic manipulation of naive mice by immunization with anti-U1RNP antibodies. Pathobiology 1997; 65: 204-209. Doria A, Biasinutto C, Ghirardello A, Sartori E, Rondinone R, Piccoli A, Veller Fornasa C, Gambari PF. Photosensitivity in systemic lupus erythematosus: laboratory testing of ARA/ACR definition. Lupus 1996; 5: 263-268. Ghirardello A, Doria A, Vesco P, Vaccaro E, Bernardi C, Fagiolo U, Gambari PF. Blotting pattern of IgG Anti-(U1)RNP antibodies in mixed connective tissue disease. Rheumatol Int 1996; 16: 145150. Fiocco U, Cozzi L, Rigon C, Chieco-Bianchi F, Baldovin M, Cassisi GA, Gallo C, Doria A, Favaro MA, Piccoli A, De Candia A, Rubaltelli L, Todesco S. Arthroscopic synoviectomy in rheumatoid and psoriatic knee joint synovitis: long-term outcome. Br J Rheumatol 1996; 35: 463-470. Balestrieri G, Doria A, Galeazzi M, Meroni PL, Migliorini P, Tavoni A, Tincani A, Bombardieri S. III European Conference on Systemic Lupus Erythematosus. Conference summary. Clin Exp Rheumatol 1996; 14(S-16): S3-S16. Vitali C, Doria A, Tincani A, Fabbri P, Balestrieri G, Galeazzi M, Meroni PL, Migliorini P, Neri R, Bombardieri S. International survey on the management of patients with SLE. General data on the partecipating centers and the results of a questionnaire regarding mucocutaneous involvement. Clin Exp Rheumatol 1996; 14(S-16): S17-S22. Tincani A, Brey R, Balestrieri G, Vitali C, Doria A, Galeazzi M, Meroni PL, Migliorini P, Neri R, Tavoni A, Bombardieri S. International survey on the management of patients with SLE. The results of a questionnaire regarding neuropsychiatric manifestations. Clin Exp Rheumatol 1996; 14(S-16): S23-S30. Doria A, Vitali C, Tincani A, Balestrieri G, Galeazzi M, Meroni PL, Migliorini P, Neri R, Tavoni A, Bombardieri S. International survey on the management of patients with SLE. The results of a questionnaire regarding renal involvement. Clin Exp Rheumatol 1996; 14(S-16): S23-S30. Doria A, Ghirardello A, Boscaro M, Viero ML, Vaccaro E, Patrassi GM, Gambari PF. Fibrinolysis and coagulation abnormalities in systemic lupus erythematosus. Relationship with Raynaud's phenomenon, disease activity, inflammatory indices, anticardiolipin antibodies and corticosteroid therapy. Rheumatol Int 1995; 14: 207-11. Ghirardello A, Doria A, Ruffatti A, Rigoli A, Vesco P, Calligaro A, Gambari PF. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus (SLE). Are they specific tools for the diagnosis of aPL syndrome in SLE? Ann Rheum Dis 1994; 53: 140-2. Ghirardello A, Doria A, Gambari PF. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus (SLE). Are they specific tools for the diagnosis of aPL syndrome in SLE? (Author's reply) Ann Rheum Dis 1994; 53: 619-620. Doria A, Vesco P, Zulian F, Gambari PF. The 1982 ARA/ACR criteria for classification of systemic lupus erythematosus in pediatric age Clin Exp Rheumatol 1994; 12: 689-90. Page 15 - Curriculum vitae of LAST_NAME, FIRST_NAME Doria, Andtrea 201. Doria A, Piccoli A, Vesco P, Vaccaro E, Marson P, De Silvestro G, Ossi E, Gambari PF. Therapy of lupus nephritis: a two-year prospective study. Ann Med Interne 1994; 145: 307-311. 202. Rosada M, Fiocco U, De Silvestro G, Doria A, Cozzi L, Favaretto M, Todesco S. Effect of DPenicillamine on T cell phenotype in scleroderma. Comparison between treated and untreared patients. Clin Exp Rheumatol 1993; 11: 143-148. 203. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, D'Ascanio A, Bombardieri S, and the European Consensus Study Group for Disease Activity in SLE (Doria A et al.). Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 european lupus patients. Clin Exp Rheumatol 1992; 10: 527-39. 204. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, Neri R, Bombardieri S, and the European Consensus Study Group for Disease Activity in SLE (Doria A et al.). Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol 1992; 10: 541-47. 205. Bencivelli W, Vitali C, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, Bombardieri S, and the European Consensus Study Group for Disease Activity in SLE (Doria A et al.). Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. Clin Exp Rheumatol 1992; 10: 549-54. 206. Ramonda R, Doria A, Villanova C, Vaccaro E, Punzi L, Fasoli G, Gambari PF. Evaluation de l'atteinte cardique au cours du lupus erythemateux dissemine. etude clinique et echocardiographique. Rev Rhum 1992; 59 (12): 790-796. 207. Doria A, Di Lenardo L, Vario S, Calligaro A, Vaccaro E, Gambari PF. Cyclosporin A in a pregnant patient with systemic lupus erythematosus. Rheumatol Int 1992; 12: 77-8. 208. Doria A, Ruffatti A, Calligaro A, Del Ross T, Ghirardello A, Gambari PF. Antiphospholipid antibodies in mixed connective tissue disease. Clin Rheumatol 1992; 11: 48-50. 209. Doria A. Ghirardello A, de Zambiasi P, Ruffatti A, Gambari PF.Japanese diagnostic criteria for mixed connective tissue disease in Caucasian patients. J Rheumatol 1992; 19: 259-264. 210. Doria A, Bonavina L, Anselmino M, Ruffatti A, Favaretto A, Gambari PF, Peracchia A, Todesco S. Esophageal involvment in Mixed Connective Tissue Disease. J Rheumatol 1991; 18: 685-90. 211. Ruffatti A, Calligaro A, Del Ross T, Targa L, Ghirardello A, Doria A, Todesco S. Clinical value of a peculiar fluorescence nuclear staining in systemic sclerosis. Clin Exp Rheumatol 9: 29-34, 1991. 212. Ruffatti A, Calligaro A, Del Ross T, Bertoli MT, Doria A, Rossi L, Todesco S. Anti-double stranded DNA antibodies in the healthy elderly prevalence and characteristics. J Clin Immunol 1990;10 (6): 300-303. 213. Ruffatti A, Artifoni L, Glorioso S, Calligaro A, Doria A, Gambari PF, Todesco S. Prevalence of anticentromere antibody in blood relatives of anticentromere positive patients. J Rheumatol 1985; 12: 940-3. Page 16 - Curriculum vitae of LAST_NAME, FIRST_NAME Doria, Andtrea